Obagi HydraFactor Broad Spectrum SPF 30 Review

Scroll the reviews on Obagi's HydraFactor page and the tone is unusual for a sunscreen: thirty-one of them averaging 4.9 stars, and the most recent ones are pleas. Bring it back. Nothing else feels like this. Why was it discontinued. Obagi still lists the teal-capped pump bottle at sixty-five dollars with a note that it cannot ship to Hawaii, and retailer stock is patchy, so the product is in the odd position of being both available and, by its own customers' account, on its way out. The reason is not on the front of the tube, where it says moisturiser and sunscreen in one, but on the drug-facts panel: avobenzone one percent, octinoxate 7.5 percent, octisalate five percent, oxybenzone five percent. That is the organic filter set of 2014, the year Obagi360 launched, and in 2026 it is the filter set almost nobody will formulate with.

The cream around the filters is good, and it is the reason for the affection. Water, an alkyl benzoate ester and butyloctyl salicylate, which boosts SPF quietly, carry the filters; glycerin and sodium hyaluronate sit fifth and sixth for hydration; a hydrolysed tara gum and its parent gum form a light film that keeps water at the surface; two polymers set a gel-cream texture; and a resveratrol ferment, ubiquinone and vitamin E acetate provide an antioxidant layer that makes sense in a product whose filters shed radicals as they degrade. No fragrance, no alcohol, no oils, no silicones, no parabens. It goes on like a day cream, disappears without a cast, and leaves a soft dewy finish that makeup sits on, and for a patient using the Obagi360 retinol at night it is the daytime comfort that keeps the routine going. Every one of those five-star reviews is describing something real, and it is worth saying so before the label is read, because the label is about to make the cream sound worse than it feels.

The filters are where the review has to be blunt. Oxybenzone has been the most scrutinised sunscreen ingredient of the past decade for two separate reasons. The first is absorption: in 2020 the FDA's own scientists published a randomised trial in JAMA in which forty-eight volunteers applied four commercial sunscreens at the labelled dose over most of their bodies for four days, and every one of the six organic filters tested, oxybenzone among them, reached plasma concentrations above the 0.5 nanograms per millilitre threshold that triggers further safety assessment, oxybenzone by a very wide margin and after a single application. The authors and the agency were careful to say that absorption does not mean harm and that nobody should stop using sunscreen, and that remains the position; but the FDA asked manufacturers for more safety data on those filters, and manufacturers largely responded by reformulating without oxybenzone rather than by producing the data. The second reason is environmental: laboratory work implicating oxybenzone and octinoxate in coral bleaching led Hawaii to ban both from sale in 2021, which is the origin of the shipping note. Octinoxate, for its part, is also one of the organic filters most often positive on photoallergy patch testing, a consideration for a product sold to treated skin. None of this makes HydraFactor dangerous. All of it makes the formula a period piece, and explains why a brand would let it go rather than defend it; reformulating a four-filter organic cream without oxybenzone means rebuilding the photostability from scratch, and a ten-year-old starter line is not where a company spends that effort.

The protection it offers is adequate rather than generous. Octinoxate and octisalate deliver the SPF 30, one percent avobenzone gives a modest long-UVA floor stabilised by the oxybenzone, and the cream is applied, as moisturiser-style sunscreens tend to be, a little more thinly than a dedicated SPF; for a healthy face in ordinary daily exposure that is fine, and for a melasma or post-procedure patient it is not the shield a dermatology office would choose, which is why those patients get the brand's mineral Sun Shields instead.

At sixty-five dollars for 2.5 ounces, lasting about two months at the proper dose, the cream is priced as a dispensed product and, at the moment, as a scarce one; what the money buys is a feel that its users have not found elsewhere, from a legacy physician brand, and what it does not buy is a current filter set, deep UVA coverage, or the settled safety standing of a mineral. Obagi's own Mineral UV Barrier Protect SPF 40, with ceramides and squalane on a zinc base, is the brand's answer to the same daily-moisturiser-with-SPF brief without the footnotes.

For someone who has worn HydraFactor for years, likes it and can still find it, there is no emergency; the FDA's advice is to keep using sunscreen. For anyone choosing a moisturising SPF today, pregnant, reef-conscious, photoallergy-prone or simply reading labels, the honest recommendation is to take the idea, a hydrating antioxidant cream with SPF, and buy it with filters from this decade.